Virbac S.A (VIRP) | Financial Analysis & Statements

Virbac S.A. | Large-cap | Healthcare

€332.00

-1.63%

Virbac S.A vs bioMérieux S.A Virbac S.A vs Eurofins Scientific Virbac S.A vs Ipsen S.A Virbac S.A vs Compagnie du Virbac S.A vs Covivio S.A Virbac S.A vs CAC 40 | Market

Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 1.4B

Gross Profit 937.6M 67.10%

Operating Income 228.3M 16.34%

Net Income 145.8M 10.43%

EPS (Diluted) €17.34

Balance Sheet Metrics

Total Assets 1.8B

Total Liabilities 805.1M

Shareholders Equity 1.0B

Debt to Equity 0.77

Cash Flow Metrics

Operating Cash Flow 118.0M

Free Cash Flow 123.8M

Revenue & Profitability Trend

Virbac S.A Income Statement From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Revenue	1.4B	1.2B	1.2B	1.1B	934.2M
Cost of Goods Sold	459.8M	437.3M	426.2M	363.1M	319.9M
Gross Profit	937.6M	809.6M	790.0M	700.9M	614.3M
Operating Expenses	280.3M	247.6M	250.8M	412.2M	174.0M
Operating Income	228.3M	185.7M	183.5M	166.8M	122.9M
Pre-tax Income	207.8M	174.2M	176.4M	159.1M	173.3M
Income Tax	62.5M	53.5M	55.7M	43.6M	33.3M
Net Income	145.8M	121.1M	121.3M	115.7M	140.3M
EPS (Diluted)	€17.34	€14.38	€14.42	€13.38	€16.12

Income Statement Trend

Virbac S.A Balance Sheet From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Assets
Current Assets	844.1M	771.5M	723.5M	624.7M	569.8M
Non-Current Assets	1.0B	684.2M	610.1M	576.9M	539.7M
Total Assets	1.8B	1.5B	1.3B	1.2B	1.1B
Liabilities
Current Liabilities	464.6M	399.0M	390.6M	370.8M	311.7M
Non-Current Liabilities	340.6M	146.8M	103.7M	105.6M	142.6M
Total Liabilities	805.1M	545.8M	494.3M	476.4M	454.3M
Equity
Total Shareholders Equity	1.0B	909.9M	839.3M	725.2M	655.2M

Balance Sheet Composition

Virbac S.A Cash Flow Statement From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Operating Activities
Net Income	145.8M	121.1M	121.3M	115.7M	140.3M
Operating Cash Flow	118.0M	87.6M	45.2M	75.0M	110.0M
Investing Activities
Capital Expenditures	-69.2M	-41.0M	-38.7M	-33.7M	-22.5M
Investing Cash Flow	-417.7M	-103.4M	-38.7M	-39.6M	-22.5M
Financing Activities
Dividends Paid	-11.1M	-11.2M	-10.6M	-6.3M	-
Financing Cash Flow	155.8M	27.0M	-20.5M	-73.7M	-328.4M
Free Cash Flow	123.8M	58.7M	45.4M	82.7M	89.9M

Cash Flow Trend

Virbac S.A Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 18.60

Forward P/E 16.24

Price to Book 2.59

Price to Sales 1.93

PEG Ratio 16.24

Profitability Ratios

Profit Margin 10.40%

Operating Margin 11.52%

Return on Equity 14.93%

Return on Assets 8.66%

Financial Health

Current Ratio 1.82

Debt to Equity 29.98

Beta 0.84

Per Share Data

EPS (TTM) €17.34

Book Value per Share €124.56

Revenue per Share €166.89

Peer Financial Comparison

Company	Market Cap	P/E Ratio	P/B Ratio	ROE	Profit Margin	Debt/Equity
virp	2.7B	18.60	2.59	14.93%	10.40%	29.98
bioMérieux S.A	14.2B	32.96	3.37	10.68%	10.86%	11.65
Eurofins Scientific	10.6B	28.48	2.56	7.71%	5.85%	67.05
Ipsen S.A	8.4B	23.61	1.99	8.93%	9.68%	12.33
Compagnie du	6.4B	150.00	1.18	0.76%	128.75%	0.73
Covivio S.A	5.7B	81.59	0.69	1.65%	6.09%	90.76

Financial data is updated regularly. All figures are in the company's reporting currency.